Who we are

We have gathered experts in their fields from across the life-sciences spectrum. We’re all individuals, we all have niche skill sets, but we all share a common passion to expand the boundaries of knowledge in clinical trials in the pursuit of developing new medicines. We set out to defy the conventional – not only do we believe that we can solve the challenges you face; we believe that together, we can solve the challenges you didn’t even know you had.


Johannes Hulthe Antaros Medical

Johannes Hulthe MD, PhD, MSc Bus Adm

Johannes is an associate professor in Cardiovascular Prevention at the Sahlgrenska University Hospital, Sweden. He has 12 years’ experience of the pharma industry, from all stages of pharmaceutical development – from conception of ideas, target identification/validation, pre-clinical development, translational medicine and biomarker development, early clinical development and proof of concept, as well as late clinical development, regulatory approval and life cycle management.

Johannes has a strong scientific background in areas of atherosclerosis, dyslipidemia, metabolism, diabetes and imaging. To date, he has more than 80 papers published in peer-reviewed journals.

Prior to co-establishing Antaros Medical, Johannes was VP Global Clinical Development for cardiovascular and metabolic diseases at AstraZeneca, where he was responsible for all clinical programs from Phase III through regulatory approval and life cycle management.

His other relevant experience includes patent applications, portfolio leadership and asset assessment.


Lars Johansson Antaros Medical

Lars Johansson, PhD

Lars is an Associate Professor of Translational Imaging at Uppsala University, Sweden. He has led a large number of international multi-center imaging trials, and has been PI and co-PI on international grants from EU, JDRF, NIH and EFSD. He has more than 120 peer-reviewed publications in the cardiovascular and metabolism field, with a primary focus on imaging, and more than 20 years’ experience of the medical and pharma Industries. During his last 10 years at AstraZeneca, he was Senior Principal Scientist, a role in which he was involved in projects ranging from pre-clinical to life cycle management. He has also led several collaborations between industry and academia.


Joel Kullberg Antaros Medical

Joel Kullberg, PhD

Joel is an Associate Professor of Radiology at Uppsala University. His primary research focus is the development, validation, and application of medical imaging techniques. He has more than 60 peer-reviewed publications, and holds a Master’s of Science in Engineering Physics, (2004), and a PhD in Medical Image Analysis, (2007).

Joel is currently leading a group of researchers at the Department of Radiology at Uppsala University. The methods developed during his research have been applied in multiple national and international interventional trials, both with academia and the pharma industry. He has received multiple international awards for his scientific achievements.
Håkan Ahlström Antaros Medical

Håkan Ahlström, MD, PhD
Medical Advisor

Håkan is Head Physician at the Department of Radiology at Uppsala University Hospital, and Professor of Radiology at Uppsala University. He has been PI for more than 30 Phase 1-3 clinical trials.

Håkan either has been, or still is, a member of: the Ethics Committee of Uppsala University; the Research Committee of the European Association of Academic Radiology; the Board of European Society of Radiology Research Committee; the Scientific Advisory Board of the European Institute for Biomedical Imaging Research; the Scientific Advisory Group in Diagnostics at the European Agency for the Evaluation of Medicinal Products; and Reviewer, (Program Committee), of the Swedish Cancer Society.

He is author of more than 240 peer-reviewed publications in cardio-metabolic and oncologic imaging, and PI of the first PET/MR scanner installed in Sweden. He has also been the scientific supervisor for more than 30 PhD students.